{"summary":"Certified regulatory professional with over 9 years of FDA experience, including 6 years in a team leader role, focused on CMC regulatory strategy in support of biotechnology product (antibodies, fusion proteins, antibody drug conjugates, bispecifics, biosimilars, insulins, etc.) submissions for all phases of US product lifecycle (pre-IND, IND, BLA, and post-approval). I am ready to embrace my new role at Boehringer Ingelheim in the pursuit of benefiting patients with debilitating diseases. Life forward.","lastName":"Janelsins","objectUrn":"urn:li:member:33519773","geoRegion":"Washington DC-Baltimore Area","fullName":"Brian Janelsins","firstName":"Brian","currentPositions":[{"companyName":"Boehringer Ingelheim","description":"Focused on CMC regulatory strategy for biologic products intended and approved for US market.","title":"Senior Associate Director, CMC Regulatory Affairs","companyUrnResolutionResult":{"employeeCountRange":"10001+","headquarters":{"geographicArea":"Rhineland-Palatinate","country":"Germany","city":"Ingelheim am Rhein","postalCode":"55218","line1":"Binger Stra\u00dfe"},"website":"http:\/\/www.boehringer-ingelheim.com","flagshipCompanyUrl":"https:\/\/www.linkedin.com\/company\/boehringer-ingelheim\/","industry":"Pharmaceutical Manufacturing"},"companyUrn":"urn:li:fs_salesCompany:3235","tenureAtCompany":{"numMonths":1},"startedOn":{"month":5,"year":2024}}],"entityUrn":"urn:li:fs_salesProfile:(ACwAAAH_eJ0BPmsaZ9o78tUqVWrDyRVvjVQL9wg,NAME_SEARCH,aqr7)","profilePictureDisplayImage":{"artifacts":[{"width":100,"fileIdentifyingUrlPathSegment":"100_100\/0\/1714964315811?e=1723075200&v=beta&t=u_XhGUIYq_C55HU46oIrOLIHwyu3lZWa6nh_V2V7hew","height":100},{"width":200,"fileIdentifyingUrlPathSegment":"200_200\/0\/1714964315811?e=1723075200&v=beta&t=pET3xTFWbC-T7gHrPAzYEVi5499nFvFk6naabKjtvy4","height":200},{"width":400,"fileIdentifyingUrlPathSegment":"400_400\/0\/1714964315811?e=1723075200&v=beta&t=M6c4wx2bVlp542mre4H1kJ6p4Gugp7zREFQh7PjIg6M","height":400},{"width":800,"fileIdentifyingUrlPathSegment":"800_800\/0\/1714964315811?e=1723075200&v=beta&t=2ej4fvGLc8i2n1oq6YP_LWjL86o5N7pPqJTko7iueSY","height":800}],"rootUrl":"https:\/\/media.licdn.com\/dms\/image\/D4E03AQHAMSLuz4folQ\/profile-displayphoto-shrink_"},"projects":[],"contactInfo":{},"industry":"Biotechnology Research","educations":[{"endedOn":{"year":2010},"degree":"PhD (honors)","eduId":49425697,"schoolUrn":"urn:li:fs_salesSchool:3463","school":"urn:li:fs_salesSchool:3463","fieldsOfStudy":["Immunology"],"schoolName":"University of Pittsburgh School of Medicine","startedOn":{"year":2004}},{"endedOn":{"year":2004},"degree":"B.S. (Cum Laude)","eduId":97317747,"schoolUrn":"urn:li:fs_salesSchool:21525","school":"urn:li:fs_salesSchool:21525","fieldsOfStudy":["Biology"],"schoolName":"Mary Washington College","startedOn":{"year":2000}}],"skills":[{"numOfEndorsement":0,"name":"Interpersonal Skills"},{"numOfEndorsement":0,"name":"Mentoring"},{"numOfEndorsement":0,"name":"Risk-Based Assessments"},{"numOfEndorsement":0,"name":"Critical Thinking"},{"numOfEndorsement":0,"name":"Multitasking"},{"numOfEndorsement":0,"name":"Time Management"},{"numOfEndorsement":0,"name":"Cross-Functional Team Building"},{"numOfEndorsement":0,"name":"Team Leadership"},{"numOfEndorsement":0,"name":"Project Management"},{"numOfEndorsement":0,"name":"Regulatory Affairs"},{"numOfEndorsement":0,"name":"Biopharmaceuticals"},{"numOfEndorsement":0,"name":"Public Health"},{"numOfEndorsement":0,"name":"Monoclonal Antibodies"},{"numOfEndorsement":0,"name":"Immunology"},{"numOfEndorsement":0,"name":"Mucosal Immunology"},{"numOfEndorsement":0,"name":"Neuropeptides"},{"numOfEndorsement":0,"name":"Multi-color Flow Cytometry"},{"numOfEndorsement":0,"name":"qRT-PCR"},{"numOfEndorsement":0,"name":"Luminex"},{"numOfEndorsement":0,"name":"ELISA"},{"numOfEndorsement":0,"name":"ELISPOT"},{"numOfEndorsement":0,"name":"CD4+ and CD8+ T cell-based assays"},{"numOfEndorsement":0,"name":"Dendritic Cell-based assays"},{"numOfEndorsement":0,"name":"Mouse Handling"},{"numOfEndorsement":0,"name":"Mouse genotyping"},{"numOfEndorsement":0,"name":"Mouse Models"},{"numOfEndorsement":0,"name":"Primary Cell Isolation"},{"numOfEndorsement":0,"name":"Mouse injections"},{"numOfEndorsement":0,"name":"Infectious disease mouse models"},{"numOfEndorsement":0,"name":"Bacterial Cell Culture"},{"numOfEndorsement":0,"name":"Dendritic Cells"},{"numOfEndorsement":0,"name":"qPCR"},{"numOfEndorsement":0,"name":"Biochemistry"},{"numOfEndorsement":0,"name":"Cancer"},{"numOfEndorsement":0,"name":"Cell"},{"numOfEndorsement":0,"name":"DNA"},{"numOfEndorsement":0,"name":"Immunohistochemistry"},{"numOfEndorsement":0,"name":"Molecular Biology"}],"numOfConnections":276,"patents":[],"headline":"Senior Associate Director, US Product CMC Regulatory Affairs","courses":[],"certifications":[{"endedOn":{"month":9,"year":2026},"companyUrn":"urn:li:fs_salesCompany:306225","url":"https:\/\/bcert.me\/shmallulu","authority":"Regulatory Affairs Professionals Society (RAPS)","name":"RAC-DRUGS (GLOBAL)","company":"urn:li:fs_salesCompany:306225","startedOn":{"month":8,"year":2023}}],"memberBadges":{"premium":false,"openLink":false,"jobSeeker":false},"flagshipProfileUrl":"https:\/\/www.linkedin.com\/in\/brian-janelsins-025286b","organizations":[],"location":"Washington DC-Baltimore Area","publications":[{"publishedOn":{"month":1,"day":7,"year":2014},"description":"*first author publication","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/24344308\/","name":"Altered inactivation of commensal LPS due to acyloxyacyl hydrolase deficiency in colonic dendritic cells impairs mucosal Th17 immunity","publisher":"Proc Natl Acad Sci U S A","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAH_eJ0BPmsaZ9o78tUqVWrDyRVvjVQL9wg,NAME_SEARCH,aqr7)"}]},{"name":"Oral delivery of IL-27 recombinant bacteria attenuates immune colitis in mice","publishedOn":{"month":10,"day":8,"year":2013},"publisher":"Gastroenterology","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/24120477\/","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAH_eJ0BPmsaZ9o78tUqVWrDyRVvjVQL9wg,NAME_SEARCH,aqr7)"}]},{"name":"Parental dietary fat intake alters offspring microbiome and immunity","publishedOn":{"month":9,"day":15,"year":2013},"publisher":"J Immunol.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/23935191\/","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAH_eJ0BPmsaZ9o78tUqVWrDyRVvjVQL9wg,NAME_SEARCH,aqr7)"}]},{"publishedOn":{"month":4,"day":11,"year":2013},"description":"*first author publication","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/23365459\/","name":"Neurokinin-1 receptor agonists bias therapeutic dendritic cells to induce type 1 immunity by licensing host dendritic cells to produce IL-12","publisher":"Blood","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAH_eJ0BPmsaZ9o78tUqVWrDyRVvjVQL9wg,NAME_SEARCH,aqr7)"}]},{"name":"Prostaglandin E2 suppresses antifungal immunity by inhibiting interferon regulatory factor 4 function and interleukin-17 expression in T cells","publishedOn":{"month":4,"day":20,"year":2012},"publisher":"Immunity","url":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22464170","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAH_eJ0BPmsaZ9o78tUqVWrDyRVvjVQL9wg,NAME_SEARCH,aqr7)"}]},{"publishedOn":{"month":3,"day":26,"year":2009},"description":"*first author publication","url":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18987361","name":"Proinflammatory tachykinins that signal through the neurokinin 1 receptor promote survival of dendritic cells and potent cellular immunity","publisher":"Blood","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAH_eJ0BPmsaZ9o78tUqVWrDyRVvjVQL9wg,NAME_SEARCH,aqr7)"}]},{"name":"Differential capability of human cutaneous dendritic cell subsets to initiate Th17 responses","publishedOn":{"month":1,"day":15,"year":2009},"publisher":"J Immunol.","url":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19124735","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAH_eJ0BPmsaZ9o78tUqVWrDyRVvjVQL9wg,NAME_SEARCH,aqr7)"}]},{"name":"In vivo signaling through the neurokinin 1 receptor favors transgene expression by Langerhans cells and promotes the generation of Th1- and Tc1-biased immune responses","publishedOn":{"month":6,"day":1,"year":2007},"publisher":"J Immunol.","url":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17513750","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAH_eJ0BPmsaZ9o78tUqVWrDyRVvjVQL9wg,NAME_SEARCH,aqr7)"}]},{"name":"2018 White Paper on Recent Issues in Bioanalysis: focus on flow cytometry, gene therapy, cut points and key clarifications on BAV (Part 3 - LBA\/cell-based assays: immunogenicity, biomarkers and PK assays","publishedOn":{"month":12,"day":10,"year":2018},"publisher":"Bioanalysis","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/30488726\/","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAH_eJ0BPmsaZ9o78tUqVWrDyRVvjVQL9wg,NAME_SEARCH,aqr7)"}]},{"name":"Anti-drug Antibody Validation Testing and Reporting Harmonization","publishedOn":{"month":12,"day":1,"year":2021},"publisher":"AAPS J","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/34853961\/","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAH_eJ0BPmsaZ9o78tUqVWrDyRVvjVQL9wg,NAME_SEARCH,aqr7)"}]},{"name":"FDA Approval Summary: Margetuximab plus Chemotherapy for Advanced or Metastatic HER2-Positive Breast Cancer","publishedOn":{"month":4,"day":14,"year":2022},"publisher":"Clin Cancer Res","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/34916216\/","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAH_eJ0BPmsaZ9o78tUqVWrDyRVvjVQL9wg,NAME_SEARCH,aqr7)"}]}],"positions":null,"posts":[{"createdAt":1714965960000,"insightId":"6f2114bd-044f-4545-93a9-3eb809318040","activityUnion":{"postActivity":{"contentSummaryUnion":{"referenceContentSummary":{"entityUrn":"urn:li:celebrateJobChange:7193088787919372288"}},"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":59},{"type":"PRAISE","count":21}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:ugcPost:7193088788783341568","threadUrn":"urn:li:ugcPost:7193088788783341568","reactionsCount":80,"commentsCount":19,"canComment":true},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7193088788783341568","message":{"attributes":[{"start":154,"length":20,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:3235"}}}],"text":"After nearly 10 wonderful years at the FDA, I'm happy to share that I\u2019m starting a new position as a Senior Associate Director, CMC Regulatory Affairs at Boehringer Ingelheim! Life forward."},"entityUrn":"urn:li:ugcPost:7193088788783341568"}}}]}